EDTUTC-4 New YorkLog in Sign up

ELVN
Enliven Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT

46.97USD+1.645%(+0.76)1,123,209

Pre-marketOct 2, 2026 9:08:30 AM EDT

47.21USD+2.164%(+1.00)

ELVN News

Day breaks

03:26 AM EDTMorgan Stanley initiates Enliven Therapeutics stock at overweight ·

Investing.com

07:44 AM EDTThese ten healthcare stocks posted the biggest one-month losses ·

Seeking Alpha

03:32 AM EDTEnliven Therapeutics stock initiated at Overweight by JPMorgan ·

Investing.com

06:59 AM EDTLink Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million ·

PR Newswire

02:31 AM EDTEnliven Therapeutics CMO Helen Collins sells $251k in shares ·

Investing.com

12:46 AM EDTEnliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock ·

Investing.com

10:10 AM EDT10 mid-cap healthcare stocks with the strongest momentum grades ·

Seeking Alpha

09:45 AM EDTThese mid-cap stocks have A+ momentum grades and over 100% YTD growth ·

Seeking Alpha

06:31 PM EDTEnliven Therapeutics, Inc. (ELVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

12:20 PM EDTEnliven Therapeutics at Morgan Stanley conference: cash, trials and CML ·

Investing.com

01:00 PM EDTChronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight ·

GlobeNewswire Inc.